ARMP (Armata Pharmaceuticals) Common Stock: $0.37 Mil (As of Mar. 2026)


ARMP Armata Pharmaceuticals Inc ARMP
27 GF Score
Price $7.40
! 3 Warning Signs
View Full Analysis

What is Armata Pharmaceuticals Common Stock?

Armata Pharmaceuticals ARMP +13.85% 27 Common Stock is $0.37 Mil as of Mar. 2026. GuruFocus rates ARMP with a GF Score™ of 27/100. The stock has 3 warning signs investors should review.

Armata Pharmaceuticals's quarterly common stock increased from Sep. 2025 ($0.36 Mil) to Dec. 2025 ($0.36 Mil) and increased from Dec. 2025 ($0.36 Mil) to Mar. 2026 ($0.37 Mil).

Armata Pharmaceuticals's annual common stock increased from Dec. 2023 ($0.36 Mil) to Dec. 2024 ($0.36 Mil) and increased from Dec. 2024 ($0.36 Mil) to Dec. 2025 ($0.36 Mil).

Armata Pharmaceuticals Common Stock Historical Data

* Premium members only.

The historical data trend for Armata Pharmaceuticals's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Armata Pharmaceuticals Common Stock Chart

Armata Pharmaceuticals Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.27 0.36 0.36 0.36 0.36

Armata Pharmaceuticals Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.36 0.36 0.36 0.36 0.37
ARMP
27GF Score
Armata Pharmaceuticals Inc ARMP
Common Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Armata Pharmaceuticals Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of $0.37 Mil mean?
Armata Pharmaceuticals (ARMP) has a Common Stock of $0.37 Mil as of Mar. 2026. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Armata Pharmaceuticals and its competitors.
Is Armata Pharmaceuticals' Common Stock too high?
Armata Pharmaceuticals' current Common Stock is $0.37 Mil. Overall, Armata Pharmaceuticals has a GF Score™ of 27/100, reflecting its overall financial health beyond just this single metric.
How does Armata Pharmaceuticals' Common Stock compare to SRZN and ELDN?
Armata Pharmaceuticals' Common Stock of $0.37 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Biotechnology company?
A good Common Stock depends on the Biotechnology industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Armata Pharmaceuticals and its competitors. Armata Pharmaceuticals's current Common Stock is $0.37 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Armata Pharmaceuticals stock overvalued right now?
Armata Pharmaceuticals (ARMP) has a current Common Stock of $0.37 Mil. The current Common Stock is $0.37 Mil. Armata Pharmaceuticals' overall GF Score™ is 27/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Armata Pharmaceuticals (ARMP), the current Common Stock is $0.37 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Armata Pharmaceuticals Business Description

Other Exchanges TG1N:Germany
Address 5005 McConnell Avenue, Los Angeles, CA, USA, 90066
Armata Pharmaceuticals Inc is a late clinical-stage biotechnology company focused on the development of high-purity and potent, pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using proprietary bacteriophage-based technology. It has completed three Phase 2 clinical trials to date. The Company operates and manages its business as one reportable operating segment, which is the business of developing pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat acute and chronic bacterial infections using its proprietary bacteriophage-based technology.
27GF Score

Get the complete analysis for ARMP

Common Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$7.40
Price